Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2L1 | Q07817 | 7/20 | 0.62 |
| ▸ | BCL2 | P10415 | 12/20 | 0.48 |
| ▸ | BCL2L2 | Q92843 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21751591 | 1.00 | BCL2L1 (0.62) | BCL2L1BCL2BCL2L2 | |
| SCHEMBL23164961 | 0.91 | BCL2L1 (0.51) | BCL2L1BCL2BCL2L2 | |
| SCHEMBL21751607 | 0.91 | BCL2L1 (0.51) | BCL2L1BCL2BCL2L2 | |
| SCHEMBL30857751 | 0.89 | BCL2L1 (0.61) | BCL2L1BCL2BCL2L2 | |
| SCHEMBL21751694 | 0.85 | BCL2L1 (0.51) | BCL2L1BCL2 | |
| SCHEMBL2972697 | 0.84 | BCL2L1 (0.85) | BCL2L1BCL2BCL2L2 | |
| SCHEMBL21751667 | 0.84 | BCL2L1 (0.59) | BCL2L1BCL2BCL2L2 | |
| Oxalic Acid SCHEMBL29832219 | 0.83 | BCL2L1 (0.82) | BCL2L1BCL2BCL2L2 | |
| SCHEMBL30857524 | 0.82 | BCL2L1 (0.71) | BCL2L1BCL2BCL2L2 | |
| SCHEMBL30857743 | 0.80 | BCL2L1 (0.69) | BCL2L1BCL2BCL2L2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116621860-A | Bcl-2 inhibitors | 广州麓鹏制药有限公司 | 2023-08-22 | — | — | CN | disclosed |
| CN-116425771-A | Condensed heterocyclic derivatives as Bcl-2 inhibitors for the treatment of neonatal diseases | 广州麓鹏制药有限公司 | 2023-07-14 | — | — | CN | disclosed |
| CN-116270660-A | Bcl-2/Bcl-xl inhibitor-containing composition and preparation method and application thereof | 广州麓鹏制药有限公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-116236583-A | Bcl-2/Bcl-xl inhibitor-containing composition and preparation method and application thereof | 广州麓鹏制药有限公司 | 2023-06-09 | — | — | CN | disclosed |
| CN-111511748-B | Bcl-2 inhibitors | 广州麓鹏制药有限公司 | 2023-05-02 | — | — | CN | disclosed |
| CN-111448198-A | Condensed heterocyclic derivatives as Bcl-2 inhibitors for the treatment of neonatal diseases | 新波制药有限公司 | 2020-07-24 | — | — | CN | disclosed |